N-PORT filing recap · June 2024
What did FPA Crescent Fund buy in June 2024?
Reported stock-position changes between this filing and the previous one. These are FPA Crescent Fund's own holdings, not the firm's.
Stock value
$6.33B
Positions
87
Estimated turnover
5.2%
Turnover is a proxy: verified trade-origin share changes valued at period-end and divided by average reported stock value. SEC holdings reports do not disclose execution dates or prices. Corporate actions and unreconciled activity are excluded.
New positions
MTNVail Resorts, Inc.$55.50Mreported value+308.1K sharesBIOBio-Rad Laboratories, Inc.$41.51Mreported value+152.0K sharesERFEurofins Scientific SE$11.39Mreported value+228.5K sharesMTALMetals Acquisition Corp. II$754.6Kreported value+55.1K sharesRTORentokil Initial Plc /fi$15.5Kreported value+2.7K shares
Increased positions
Reduced positions
Exited positions
PWUPAspire Biopharma Holdings, Inc.$517.4Kprior reported value-46.9K shares-100.0%MTALMetals Acquisition Corp. II$367.1Kprior reported value-180.0K shares-100.0%TWLVTwelve Seas Investment Co Iii/cayman$31.0Kprior reported value-330.0K shares-100.0%DISAWDisruptive Acquisition Corp I$0prior reported value